These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10477541)

  • 1. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association.
    Circulation; 1999 Sep; 100(10):1132-3. PubMed ID: 10477541
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Circulation; 2007 Jan; 115(1):114-26. PubMed ID: 17192512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
    Grundy SM; Benjamin IJ; Burke GL; Chait A; Eckel RH; Howard BV; Mitch W; Smith SC; Sowers JR
    Circulation; 1999 Sep; 100(10):1134-46. PubMed ID: 10477542
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].
    Avogaro A
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):5S-11. PubMed ID: 27030118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 7. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health).
    Somers VK; White DP; Amin R; Abraham WT; Costa F; Culebras A; Daniels S; Floras JS; Hunt CE; Olson LJ; Pickering TG; Russell R; Woo M; Young T; ; ; ;
    Circulation; 2008 Sep; 118(10):1080-111. PubMed ID: 18725495
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS
    Circulation; 2010 Jun; 121(24):2694-701. PubMed ID: 20508178
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes and cardiovascular disease in older adults: current status and future directions.
    Halter JB; Musi N; McFarland Horne F; Crandall JP; Goldberg A; Harkless L; Hazzard WR; Huang ES; Kirkman MS; Plutzky J; Schmader KE; Zieman S; High KP
    Diabetes; 2014 Aug; 63(8):2578-89. PubMed ID: 25060886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.
    Bairey Merz CN; Alberts MJ; Balady GJ; Ballantyne CM; Berra K; Black HR; Blumenthal RS; Davidson MH; Fazio SB; Ferdinand KC; Fine LJ; Fonseca V; Franklin BA; McBride PE; Mensah GA; Merli GJ; O'Gara PT; Thompson PD; Underberg JA; ; ; ; ; ; ; ; ; ; ;
    Circulation; 2009 Sep; 120(13):e100-26. PubMed ID: 19770387
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
    Kavey RE; Allada V; Daniels SR; Hayman LL; McCrindle BW; Newburger JW; Parekh RS; Steinberger J; ; ; ; ; ; ; ;
    Circulation; 2006 Dec; 114(24):2710-38. PubMed ID: 17130340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease.
    Eckel RH; Barouch WW; Ershow AG
    Circulation; 2002 Jun; 105(24):2923-8. PubMed ID: 12070124
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
    Lund SS; Vaag AA
    Diabetes Care; 2009 Jul; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
    [No Abstract]   [Full Text] [Related]  

  • 15. AHA examines cardiovascular problems in diabetes. American Heart Association.
    Morey SS
    Am Fam Physician; 2000 Jan; 61(2):561, 563-4, 567. PubMed ID: 10670513
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):e19-24. PubMed ID: 14766740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes mellitus--a risk factor for cardiovascular diseases].
    Skrha J
    Vnitr Lek; 2001 May; 47(5):281-4. PubMed ID: 11395868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.